DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 5Dr. Reddy's Laboratories
02 1Supriya Lifescience
03 2Accord Healthcare Pty. Ltd.
04 25Accord healthcare
05 4Accure Labs
06 2Actavis Inc
07 2Alembic Pharmaceuticals Limited
08 1Almaject
09 2Amneal Pharmaceuticals
10 3Aurobindo Pharma Limited
11 2Ayana Pharma
12 6BAXTER HEALTHCARE PTY LTD
13 2Baxter HealthCare South Africa (Pty) Ltd
14 5Baxter Healthcare Corporation
15 5Bayer AG
16 1Bluepharma
17 3Bristol Myers Squibb
18 2Cheplapharm Arzneimittel Gmbh
19 2Cipla Medpro South Africa
20 1Copharma Aps
21 1Deva Holding AS
22 1Dr Reddy's Laboratories (Pty) Ltd
23 3EBEWE Pharma Ges.m.b.H Nfg. KG
24 1Eugia Pharma
25 2Flagship Biotech International Pvt. Ltd
26 1Fresenius Kabi USA
27 2Fresenius SE & Co. KGaA
28 1GLAND PHARMA LIMITED
29 6GetWell Pharmaceutical
30 1Health Biotech
31 1Healthcare Pharmaceuticals
32 5Hikma Pharmaceuticals
33 1Intelliscend
34 2Janssen-Cilag
35 2Jodas Expoim Pvt. Ltd
36 3Key Oncologics
37 2Lupin Ltd
38 3Naprod Life Sciences
39 2Nishchay Pharmaceuticals Pvt. Ltd.
40 4Oethmaan Biosims
41 1PHARMOBEDIENT
42 1Panacea Biotec Limited
43 2Pfizer Consumer Healthcare
44 32Pfizer Inc
45 5Pharmachemie
46 8Pharmachemie (Pty) Ltd
47 1Pharmaplan
48 1Powercliff Limited
49 3SEACROSS PHARMACEUTICALS
50 1STADA Arzneimittel
51 1Sagent Pharmaceuticals
52 3Sakar Healthcare
53 8Sandoz B2B
54 1Sanoswiss Uab
55 10Sun Pharmaceutical Industries Limited
56 1Taro Pharmaceutical Industries
57 1Tedec Meiji Farma
58 15Teva Pharmaceutical Industries
59 4TherDose Pharma
60 4Viatris
61 2Vinkem Labs Ltd
62 1Zhejiang Hisun Pharmaceutical
63 2Zydus Lifesciences
01 2Concentrate For Dispersion For Infusion
02 4Concentrate For Infusion Solution
03 14Concentrate For Solution For Infusion
04 4Concentrate to the infusion fluid
05 1Concentrate to the infusion fluid, resolution
06 1Doxorubicin 100Mg 50Ml 1 Units Parenteral Use
07 6Doxorubicin 10Mg 5Ml 1 Units Parenteral Use
08 3Doxorubicin 200Mg 100Ml 1 Units Parenteral Use
09 1Doxorubicin 20Mg 10Ml 1 Units Parenteral Use
10 1Doxorubicin 50Mg 1 Unit Parenteral Use
11 1Doxorubicin 50Mg 2 Units Parenteral Use
12 4Doxorubicin 50Mg 25Ml 1 Units Parenteral Use
13 11INF
14 23INJ
15 16INJECTABLE, LIPOSOMAL;INJECTION
16 38INJECTABLE;INJECTION
17 6INJECTION
18 1Infusion Dispersion
19 4Injectable Solution
20 1Injectable; Injection
21 22Injection
22 5Injection fluid, resolution
23 1Liposomal Injection
24 1Liposome Injection
25 1Liquid Injection
26 2Lyo.Inj
27 2Lyophilised Injection
28 1POI
29 2POWDER FOR SOLUTION
30 2Powder For Concentrate For Solution For Infusion
31 1Powder For Dispersion Concentrate For Infusion
32 1Powder For Injectable Solution
33 1Powder For Solution For Injection
34 1Powder and liquids to concentrate for infusion, liposomaldispersjon
35 2Powder for injection fluid, resolution
36 2SOL
37 6SOLUTION
38 2SUSPENSION
39 14Solution For Injection
40 1Vial
41 16Blank
01 21Allowed
02 7Approved
03 8Authorized
04 1Cancelled
05 22DISCN
06 7Deregistered
07 45Generic
08 2Lead Market Dossiers- Approved in US and Under review in EU
09 1Lead Market Dossiers- Filed
10 6Originator
11 7Prescription
12 32RX
13 69Blank
01 2ADRIAMYCIN PFS
02 8Adriamycin
03 2Adriblastin RD
04 3Adriblastin Solution
05 5Adriblastina
06 1Adriblastina CSV 10mg/5ml
07 1Adriblastina CSV 50mg/25ml
08 1Adriblastina RD 10mg
09 1Adriblastina RD 50mg
10 1CAELYX
11 11Caelyx
12 3Caelyx Pegylated Liposomal
13 1Celdoxome Pegylated Liposomal
14 1Cipla Doxorubicin 10
15 1Cipla Doxorubicin 50
16 2DOXIL (LIPOSOMAL)
17 1DOXOPEG
18 4DOXORUBA
19 1DOXORUBICIN
20 1DOXORUBICIN -SOL PCH 10MG
21 1DOXORUBICIN 10mg/5ml FRESENIUS
22 1DOXORUBICIN 50mg/25ml FRESENIUS
23 33DOXORUBICIN HYDROCHLORIDE
24 14DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
25 2DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
26 1DOXORUBICIN HYDROCHLORIDE INJECTION
27 1DOXORUBICIN INJECTION, BP
28 1DOXORUBICIN-SOL PCH 50MG
29 2DOXOTHER
30 1Doxolip
31 1Doxonish 10
32 1Doxonish 50
33 10Doxorubicin
34 1Doxorubicin "Ebewe" 10mg (5ml vial)
35 1Doxorubicin "Ebewe" 50mg (25ml vial)
36 1Doxorubicin - Pch 10
37 2Doxorubicin ACC
38 11Doxorubicin Accord
39 1Doxorubicin Accord 10mg/5ml
40 1Doxorubicin Accord 50mg/25ml
41 2Doxorubicin Accord liposomal
42 1Doxorubicin Aurovitas
43 1Doxorubicin Copharma
44 4Doxorubicin Ebewe
45 2Doxorubicin Mylan
46 1Doxorubicin Pch
47 1Doxorubicin Pch 10 10Mg Vial
48 1Doxorubicin Pch 50
49 1Doxorubicin Rtu
50 1Doxorubicin Rtu 10-5 5Ml
51 1Doxorubicin Rtu 200-100 100Ml
52 1Doxorubicin Rtu 50-25 25Ml
53 4Doxorubicin Sandoz eco
54 1Doxorubicin Sanoswiss
55 1Doxorubicin Stada
56 2Doxorubicin Teva
57 1Doxorubicin hcl faulfing powder vial
58 1Doxorubicin-Hexal 10Mg/5Ml
59 1Doxorubicin-Hexal 50Mg/25Ml
60 4Doxorubicin-Teva
61 1Doxorubicina Tedec
62 1Doxred 10 Lyophilized Powder
63 1Doxred 10mg/5ml
64 1Doxred 50 Lyophilized Powder
65 1Doxred 50mg/25ml
66 2Farmiblastina
67 2I-DOX
68 6Liposomal Doxorubicin SUN
69 2Myocet
70 2Myocet Liposomal
71 3RUBEX
72 1Rubexet 10mg/5ml
73 1Rubexet 200mg/100ml
74 1Rubexet 50mg/25ml
75 1Sopilcin 20 mg/10 ml
76 1TARO-DOXORUBICIN LIPOSOMAL
77 2Zolsketil Pegylated Liposomal
78 29Blank
01 16Australia
02 7Canada
03 35India
04 17Italy
05 13Norway
06 1Portugal
07 37South Africa
08 9Spain
09 14Sweden
10 21Switzerland
11 1Turkey
12 54USA
13 3United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG/10ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 50MG/25ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 1995-11-17
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2000-06-13
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RUBEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-04-13
Application Number : 62926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RUBEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1989-04-13
Application Number : 62926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1985-05-20
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/VIAL
Packaging :
Approval Date : 1987-07-22
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2MG/ML
Packaging :
Approval Date : 1987-12-23
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 200MG/100ML
Packaging :
Approval Date : 1988-05-03
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/75ML
Packaging :
Approval Date : 2011-03-28
Application Number : 50629
Regulatory Info : DISCN
Registration Country : USA
